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1. Introduction 
Neurotoxins are very important tools for the 
analysis of molecular aspects of nerve conduction 
and transmission. Toxic molecules already available 
for study of molecular aspects of conduction include: 
0) Tetrodotoxin and saxitoxin, which are highly 
specific for blocking the Na ÷ channel in most 
axons [1,2]. 
(ii) Veratridine and batrachotoxin which depolarize 
nerve or muscle membranes by a selective 
increase in the resting sodium permeability [3,4]. 
(iii) Scorpion neurotoxin, a miniprotein which affects 
the closing of the Na ÷ channel and the opening of 
the K ÷ channel [5,6]. 
A series of neurotoxins was recently isolated in the 
pure form from the sea anemone Anemonia sulcata 
[7]. The sequence of one of these neurotoxins, ATXII, 
has now been established. It is a miniprotein compris- 
ing only 47 amino acids (5000 mol. wt) crosslinked by 
three disulfide bridges [8]. This neurotoxin has been 
described as a useful tool for the analysis of the 
molecular aspects of nerve conduction [9] and of the 
coupling between excitation and secretion in synapses 
[10]. It also displays a strong cardiotoxic action [11]. 
Among the polypeptide neurotoxins i olated from 
Anemonia sulcata, one, which has been called toxin 
III, has a particularly low mol. wt approx. 2700, 
which corresponds to a sequence of less than 30 
amino acids [7]. It is the primary structure of this 
toxin that we report in this paper. 
2. Materials and methods 
Toxin III was purified according to [7]. Carboxy- 
peptidases A (EC 3.4.12.2) and B (EC 3.4.12.3) 
treated with diisopropylphosphofluoridate and 
a-chymotrypsin (EC 3.4.12.1)were purchased from 
Worthington. Papain (EC 3.4.22.2) and aminopepti- 
dase M (EC 3.4.11.2) were from Sigma, imidodipepti- 
dase (EC 3.4.13.9) from Miles Lab. Sephadex G-25 
was obtained from Pharmacia nd Biogel P4 from 
Biorad Labs. Dithioerythritol, iodoacetic acid and 
sequanal grade dimethylbenzylamine came from 
Pierce Chemical C. N-Ethylmorpholine purum grade, 
tryptamine puriss were purchased from Fluka and the 
solution of ampholine (40% w/w, pH 3-10) from 
LKB p-toluene sulfonic acid, RS grade was from 
Carlo Erba. 
2.1. Toxin isoelectric point determination 
Electrofocusing of the toxin was carried out as 
described in the LKB instructions manual (1801-E.0.1). 
The dense buffer was made up of 7.5 ml 10% solution 
of ampholine and 28 g sucrose diluted to 60 ml with 
distilled water. The less dense solution in which the 
toxin (200 nmol) was dissolved constituted 2.5 ml of 
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the previous ampholine solution and 1 g sucrose. The 
electrofocusing was for 20 h at 500 V. The column 
was eluted in 4.0 ml fractions. The pH of each frac- 
tion was measured so as azaon m . 
2.2. S-Carboxymethylation 
After reduction of the half-cystine residues by 
dithioerythritol (60-fold excess over disulfide bonds) 
under nitrogen in 0.25 M Tris buffer with 5 M guani- 
dine, pH 8.60, at 40°C, for 20 h, S-carboxymethyla- 
tion was carried out as described [12] but in the 
buffer used for reduction. The modified protein 
(RCM-toxin) was recovered by gel filtration on a 
Sephadex G-25 column (3 X 75 cm) equilibrated in
0.1 M ammonium bicarbonate, atpH 8.60. 
2.5. Automatic sequential degradation 
Sequential Edman type degradations Were achieved 
in a protein Sequencer PS 100 Socosi (Saint Maur 
94100, France). The peptide program was used in 
presence of hake parvalbumin (0.4 ml solution at 
5 mg/ml) as described [15]. PTH amino acids were 
identified by gas chromatography [16] with a 
Beckman GC-65 apparatus and by thin-layer chroma- 
tography (TLC) on silica gel plates [17,18] and on 
polyamide double-faced sheets [19]. Furthermore 
acidic conversions of phenylthiohydantoins deriva- 
tives into free amino acids were performed with 5.7 N 
HC1 in presence of 0.1% SnC12, for 4 h, at 150°C [20] 
and the products analyzed on the Beckman 120 C. 
The arginine derivative was also revealed by Sakagushi's 
reaction [21] on paper strips. 
2.3. ~-Chymotrypsin digestion 
One prnol RCM-toxin was digested by c~-chymo- 
trypsin in I ml 0.2 M ammonium bicarbonate, 
pH 8.0, at 37°C, for 12 h, with a final enzyme to 
substrate ratio of 5% (w/w): 1% enzyme was added 
to initiate the digestion, then four additions of the 
same amount of enzyme were made at I h intervals. 
The digest was directly applied on a column of 
Biogel P4 (2 × 200 cm) equilibrated in 0.1 M ammo- 
nium acetate buffer, at pH 8.60. 
2.6. C-Terminal determination 
The RCM toxin (100 nmol) was dissolved in 0.2 M 
N-ethylmorpholine buffer, pH 8.0 and digested by 
carboxypeptidase A, at 35°C, with 5% enzyme (w/w). 
In a second experiment, after 6 h digestion by carboxy- 
peptidase A, carboxypeptidase B was added in an 
enzyme to substrate ratio of 1/25 on a molar basis. In 
both cases, aliquots of digest were removed after 15, 
30, 60 and 360 rain, acidified with 1.0 N HC1 (0.1 ml), 
freeze dried and subjected to amino acid analysis. 
2.4. Peptides amino acid compositions 
Amino acid compositions of peptides were deter- 
mined after 20 h hydrolysis in 5.7 N HC1, at 110°C. 
The determination f tryptophan residues was per- 
formed according to [ 13], the hydrolysis being 
achieved by the p-toluene sulfonic acid in the presence 
of tryptamine for 20 h, at 110°C, in vacuum-sealed 
tubes. Some peptides have been completely hydro- 
lyzed enzymatically by the procedure [14]. The pep- 
tides (about 100 t~g) were first hydrolyzed by papain 
(5/~g) in ammonium acetate buffer (0.05 M, pH 5.35) 
during 2 h at 37°C. After lyophilisation, the residue 
was submitted to the action of aminopeptidase M 
(I 50/ag) in presence of imidodipeptidase (10/ag) in 
trimethylamine/acetic acid buffer, pH 8.2. In both 
cases, hydrolysis were achieved in presence of mer- 
captoethanol (5pl 1 : 32 solution in water). Amino 
acid analysis was performed on a Beckman model 
120 C Analyzer. 
3. Results and discussion 
The automated Edman degradation of the RCM 
toxin (300 nmol) allowed us to determine directly the 
sequence of amino acids till to the lysine at position 
26, except for the two positions 2 and 23 (see fig.l) 
which remained ambiguous due to low yields. All the 
amino acid derivatives were determined by at least 
two of the identification procedures described in 
Materials and methods. 
The chymotryptic peptides were obtained after 
chromatography of the RCM toxin digest on a Biogel 
P4 column (fig.2). The different fractions were 
analyzed for their amino acid compositions ( ee 
table 1) and C 1 (200 nmol), CII I (170 nmol) and C v 
(200 nmol) have been sequenced by the automated 
Edman degradation procedure. 
Results are shown also on fig.1. The identification 
by TLC at positions 2 and 23 of the serine residues as 
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Fig.1. Amino-acid sequences of toxin III ofAnemonia sulcata. Horizontal arrows ( "-) indicate the positions determined by 
Edman degradation: (a) on the complete protein; (b) on chymotryptic peptides. The dotted arrows ( -  - ~-) express ome 
ambiguity in the direct identification. (CPA) shows the amino-acid released by action of carboxypeptidase A on RCM toxin. 
(c) Peptides identified by amino acid analysis. 
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Fig.2. Eiution pattern of the chymotryptie digest of RCM toxin on a Biogel P4 column (2 × 200 cm) equilibrated in 0.1 M 
ammonium acetate buffer, pH 8.6, flow rate 12 ml/h. Full line, A 2~0 rim. Dotted line, A 28o nm. 
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Table 1 
Amino acid compositions of the RCM toxin and of the chymotryptic fragments 
Amino acids RCM toxin C I CII CII I C V CVI 
Aspartic acid 1.1 (1) 1.1 (1) 1.0 (1) 1.0 (1) 
Threonine 
Serine 1.7 (2) 1.0 (1) 1.0 (1) 1.1 (1) 1.2 (1) 
Glutamic acid 2.0 (2) 2.0 (2) 2.0 (2) 2.1 (2) 
Proline 4.2 (4) 2.8 (3) 2.3 (2) 2.2 (2) 1.2 (1) 0.9 (1) 
Glycine 4.9 (5) 4.8 (5) 3.1 (3) 2.9 (3) 2.0 (2) 
Alanine 
CM-cysteine 5.5 (6) 2.9 (3) 2.2 (2) 2.0 (2) 3.0 (3) 1.0 (1) 
Valine 1.0 (1) 1.0 (1) 1.0 (1) 1.0 (1) 
Methionine 
Isoleucine 
Leucine 
Tyrosine 1.7 (2) 0.9 (1) 0.8 (1) 0.9 (1) 1.0 (1) 
Phenylalanine 
Histidine 
Lysine 1.0 (1) 0.9 (1) 1.0 (1) 
Arginine 1.2 (1) 0.9 (1) 
Tryptophan 2.0 a (2) +b (1) 
1.0 (1) 
+b (1) 
Total (27) (19) (14) (14) 
Sequence positions 
of peptides 9-27 14-27 14-27 
Yield (%) 22 16 40 
1-8 
63 
(8) 
+b (1) 
(5) 
9-13 
34 
a Tryptophan determination according [ 13 ] 
b Ehrlich's reaction 
PTH derivatives remained slightly ambiguous; however 
acidic conversions of  these derivatives showed the 
presence of  serine. Finally the amino acid composi- 
tions of CII I and C V, both after acidic and enzymatic 
hydrolysis, clearly stated the presence of one residue 
of serine in each of these peptides that could only be 
placed at the above mentioned positions. According 
to amino acid composition, fraction CVI should 
correspond to positions 9 -13 .  The amino acid compo- 
sitions of fractions CII and CII I are identical. There- 
fore, we assumed the same location in the sequence 
for these two peptides, although no satisfactory 
explanation has been found with regard to their 
different elution on Biogel P4. The action of  carboxy- 
peptidase A and B showed only the release of 1 Val/ 
mol toxin. Lysine at position 26 was not released 
probably due to the presence of  proline at position 25. 
The amino acid sequence of  toxin III of Anemonia 
sulcata, as shown on fig.l, is in complete agreement 
with the amino acid composition of  the RCM toxin 
(table 1) and consistent with the isoelectric point of 
the native toxin, estimated to be near 8.1 by 
electro focusing. 
The remarkable features of the toxin III sequence 
are the following: 
(i) The toxin is only 27 amino acids long and rich in 
disulfide bridges. 
0i) Eight amino acids are not represented at all in 
this toxin sequence, Met, Leu, lie, Phe, Thr, His, 
Asp and Ala. 
(iii) Aromatic residues are abundant (2 Tyr, 2 Trp) as 
well as glycine residues which nearly make up 
20% of the total amino acid content. 
(iv) There are three main regions in the sequence, the 
N-terminal dipeptide which is very polar, the 
sequence from residues 3 -14  which is predomi- 
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nantly hydrophobic and the C-terminal part of 
the molecule which has again a polar character. 
There is no evident extensive sequence homology 
between toxin II, the 47 amino acids long toxin and 
toxin III sequenced in this paper. The only common 
sequence isGly-Cys-Pro which is in positions 
10-13 in toxin III and in positions 26-28 in toxin 
II [7]. It is of interest o remark that this sequence is
in both cases in a very hydrophobic region of the 
molecule (region 21-31 in toxin II). This hydrophobic 
region containing both in toxin II and in toxin III two 
tryptophan which sit on each side of the common 
sequence Gly-Cys-Pro. Although toxin II and toxin 
III appear to have considerable differences in primary 
structure, their mode of action on crayfish nerves 
does not exhibit such discrepancies. Toxin III similarly 
to toxin II [9] considerably prolongs the action 
potential of crayfish nerves at concentrations a  low as 
10 -s M (Cavey, M. T., Romey, G. and Lazdunski, M., 
in preparation), its main effect being the prevention of 
the closing step of the sodium channel. However toxin 
III displays a veratridin-like depolarizing action which 
is more accentuated than that observed for toxin II 
at low concentrations. Nevertheless the presently 
available pharmacological results show that although 
the two toxins have very different sequences, they 
have essentially the same type of mode of action. 
Until now important sequence homologies have been 
found within the class of snake neurotoxins [22] or 
within the class of scorpion eurotoxins [23]. The 
situation seems to be different within the class of the 
sea-anemone toxins (which, as a matter of fact, have 
no homology with snake or scorpion eurotoxins). 
The small size of toxin III from Anemonia sulcata 
makes it particularly interesting for structure-fuc- 
tion analysis using the peptide synthesis approach. 
Toxin III is after apamin (18 amino acids and 2 di- 
sulfide bridges), the smallest polypeptidic neurotoxin 
actually known. 
Just as this paper was ready for submission, the 
complete amino-acid sequence of the same toxin was 
published [24] ; the determination f this sequence 
was performed using Edman degradation i solid- 
phase. All the results were in agreement with those 
exposed here, except for residues 22 and 23, the 
sequence Ser-Cys in place of Cys-Ser. We determined 
these positions on the whole RCM toxin and confirmed 
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Fig.3. Thin-layer chromatography on silica gel plates (Edman 
solvent H) of the PTH amino acids obtained from the 
sequencing ofpeptide CII I (residues 14-27 in the sequence 
of the toxin). Reference mixtures are indicated by horizont~d 
bars: (-), (=) (=--) as described [17,18]. 
by the sequencing of the chymotryptic peptide Cm, 
as shown on fig.3. This clearly demonstrates the 
presence of a residue of carboxymethylcysteine in 
position 22. 
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